Sérgio Valente

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression”.

Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression

Gastroenterology(2021)10.1053/j.gastro.2021.06.045

N/A

2.8DataRank · unranked

124 citations

Surendra K. Shukla, Enza Vernucci, Chunbo He, Dezhen Wang, Ryan J. King +26 more

Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors

EMBO Reports(2022)10.15252/embr.202254721

N/A

0.760DataRank · unranked

22 citations

Luca Tucciarone, Elisa Macrì, Marco De Bardi, Mario Picozza, Illari Salvatori +6 more

Quinoline-based compounds can inhibit diverse enzymes that act on DNA

Cell chemical biology(2024)10.1016/j.chembiol.2024.09.007

N/A

0.330DataRank · unranked

8 citations

Qin Chen, Ren Ren, Jie Yang, Bigang Liu, J.R. Horton +14 more

Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12, 447

Cancers(2024)10.3390/cancers16061230

N/A

0DataRank · unranked

0 citations

Rossella Fioravanti, Giulia Stazi, Federica Sarno, Cecilia Battistelli, Annalisa Romanelli +14 more

Quinoline-based compounds can inhibit diverse enzymes that act on DNA

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.03.587980

N/A

0DataRank · unranked

0 citations

Qin Chen, Ren Ren, Jie Yang, Bigang Liu, J.R. Horton +13 more

Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00014

N/A

0DataRank · unranked

75 citations

Giulia Stazi, Rossella Fioravanti, Clemens Zwergel, Elisabetta Di Bello, Silvia Pomella +10 more

TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia

Cancer Letters(2025)10.1016/j.canlet.2025.218011

N/A

0DataRank · unranked

1 citations

Sujung Park, Yejin Lee, Francesca Liccardo, Haeun Yang, Jeonghye Park +14 more

Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation

Cancers(2020)10.3390/cancers12020447

N/A

0DataRank · unranked

11 citations

Rossella Fioravanti, Giulia Stazi, Federica Sarno, Cecilia Battistelli, Annalisa Romanelli +14 more

Partial resistance to HDAC inhibitors in FAPs of dystrophic muscles at late stages of disease is associated to epigenetic and transcriptional features of cellular senescence

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.26.441412

N/A

0DataRank · unranked

2 citations

Luca Tucciarone, Ettore Macrì, Marco De Bardi, Mario Picozza, Illari Salvatori +6 more